Study to Evaluate the Safety, PK, and Efficacy of the Myc Inhibitor OMO-103 Administered iv in Patients With PDAC

Name: Study to Evaluate the Safety, PK, and Efficacy of the Myc Inhibitor OMO-103 Administered iv in Patients With PDAC
Published: 2023
License: Public Domain

Peptomyc S.L. · 2023

ClinicalTrials.gov · Datasets · License: Public Domain · 2023

Open Source ↗

pancreatic-cancer

metastatic pancreatic cancer, pdac, pancreatic cancer, metastatic, interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Study to Evaluate the Safety, PK, and Efficacy of the Myc Inhibitor OMO-103 Administered iv in Patients With PDAC

Related documents